Indacaterol: The First Once-daily Long-acting Beta2 Agonist for COPD

Indacaterol: The First Once-daily Long-acting Beta2 Agonist for COPD book cover

Indacaterol: The First Once-daily Long-acting Beta2 Agonist for COPD

Author(s): Alexandre Trifilieff

  • Publisher: Springer
  • Publication Date: November 27, 2013
  • Language: English
  • Print length: 156 pages
  • ISBN-10: 3034807104
  • ISBN-13: 9783034807104

Book Description

Current Pharmacotherapy for COPD.- The preclinical pharmacology of indacaterol.- The design of the indacaterol molecule.- The early clinical development of Indacaterol.- INHANCE: An adaptive confirmatory study with dose selection at interim.- Phase III clinical efficacy studies – lung function.- Phase III Clinical Efficacy of Indacaterol.- Patient-centered Outcomes.- The history and performance of the Breezhaler device.- What does the future hold for the therapy of COPD?

View on Amazon

电子书代发PDF格式价格30我要求助
未经允许不得转载:Wow! eBook » Indacaterol: The First Once-daily Long-acting Beta2 Agonist for COPD